Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Bristol-Myers Squibb buy BiotechBee

Bristol-Myers Squibb
Start price
€69.37
07.09.22 / 70%
Target price
€100.00
31.12.25
Performance (%)
-12.07%
End price
€61.00
05.05.23
Summary
This prediction ended on 05.05.23 with a price of €61.00. The price of Bristol-Myers Squibb has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.07%. Dividends of €1.61 are taken into consideration when calculating the performance. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Bristol-Myers Squibb -1.411% -1.411% 34.372% -2.336%
iShares Core DAX® 0,44 % 5,64 % 7,81 % 63,64 %
iShares Nasdaq 100 1,06 % 0,28 % 27,24 % 88,12 %
iShares Nikkei 225® 1,77 % 0,41 % 49,27 % 83,53 %
iShares S&P 500 0,37 % 1,92 % 22,34 % 68,75 %

According to BiotechBee what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Bristol-Myers Squibb diskutieren
Prediction Buy
Perf. (%) -12.07%
Target price 100.000
Change
Ends at 31.12.25

Buy mit Kursziel 100,0

BiotechBee 
0
Report Share
07.09.22
In the thread Trading Bristol-Myers Squibb
Prediction Buy
Perf. (%) -12.07%
Target price 100.000
Change
Ends at 31.12.25

Buy beendet

BiotechBee 
0
Report Share
05.05.23